nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2E1—Dexamethasone—psoriatic arthritis	0.131	0.21	CbGbCtD
Alosetron—CYP3A4—Methylprednisolone—psoriatic arthritis	0.105	0.169	CbGbCtD
Alosetron—CYP3A4—Triamcinolone—psoriatic arthritis	0.0797	0.128	CbGbCtD
Alosetron—CYP2C9—Dexamethasone—psoriatic arthritis	0.0684	0.11	CbGbCtD
Alosetron—CYP3A4—Betamethasone—psoriatic arthritis	0.0684	0.11	CbGbCtD
Alosetron—CYP3A4—Prednisolone—psoriatic arthritis	0.0675	0.108	CbGbCtD
Alosetron—CYP3A4—Prednisone—psoriatic arthritis	0.0637	0.102	CbGbCtD
Alosetron—CYP3A4—Dexamethasone—psoriatic arthritis	0.0398	0.0638	CbGbCtD
Alosetron—Colitis ulcerative—Auranofin—psoriatic arthritis	0.0329	0.0875	CcSEcCtD
Alosetron—Hypopituitarism—Methylprednisolone—psoriatic arthritis	0.0292	0.0776	CcSEcCtD
Alosetron—Cognitive disorder—Methylprednisolone—psoriatic arthritis	0.00562	0.0149	CcSEcCtD
Alosetron—Trauma—Prednisolone—psoriatic arthritis	0.00556	0.0148	CcSEcCtD
Alosetron—Trauma—Triamcinolone—psoriatic arthritis	0.00511	0.0136	CcSEcCtD
Alosetron—Cognitive disorder—Betamethasone—psoriatic arthritis	0.00511	0.0136	CcSEcCtD
Alosetron—Cognitive disorder—Dexamethasone—psoriatic arthritis	0.00511	0.0136	CcSEcCtD
Alosetron—Trauma—Methylprednisolone—psoriatic arthritis	0.0051	0.0136	CcSEcCtD
Alosetron—Trauma—Betamethasone—psoriatic arthritis	0.00464	0.0123	CcSEcCtD
Alosetron—Trauma—Dexamethasone—psoriatic arthritis	0.00464	0.0123	CcSEcCtD
Alosetron—Jaundice—Auranofin—psoriatic arthritis	0.00453	0.012	CcSEcCtD
Alosetron—Cognitive disorder—Prednisone—psoriatic arthritis	0.00445	0.0118	CcSEcCtD
Alosetron—Trauma—Prednisone—psoriatic arthritis	0.00404	0.0108	CcSEcCtD
Alosetron—Folliculitis—Triamcinolone—psoriatic arthritis	0.00387	0.0103	CcSEcCtD
Alosetron—Folliculitis—Methylprednisolone—psoriatic arthritis	0.00386	0.0103	CcSEcCtD
Alosetron—Cognitive disorder—Methotrexate—psoriatic arthritis	0.00372	0.00989	CcSEcCtD
Alosetron—Alopecia—Auranofin—psoriatic arthritis	0.00368	0.0098	CcSEcCtD
Alosetron—Dermatitis atopic—Prednisolone—psoriatic arthritis	0.00358	0.00952	CcSEcCtD
Alosetron—Flatulence—Auranofin—psoriatic arthritis	0.00358	0.00952	CcSEcCtD
Alosetron—Folliculitis—Betamethasone—psoriatic arthritis	0.00351	0.00935	CcSEcCtD
Alosetron—Folliculitis—Dexamethasone—psoriatic arthritis	0.00351	0.00935	CcSEcCtD
Alosetron—Dermatitis atopic—Triamcinolone—psoriatic arthritis	0.00329	0.00875	CcSEcCtD
Alosetron—Acne—Prednisolone—psoriatic arthritis	0.00315	0.00837	CcSEcCtD
Alosetron—Fungal infection—Methylprednisolone—psoriatic arthritis	0.00315	0.00837	CcSEcCtD
Alosetron—Acne—Triamcinolone—psoriatic arthritis	0.00289	0.0077	CcSEcCtD
Alosetron—Acne—Methylprednisolone—psoriatic arthritis	0.00289	0.00768	CcSEcCtD
Alosetron—Fungal infection—Dexamethasone—psoriatic arthritis	0.00286	0.00761	CcSEcCtD
Alosetron—Fungal infection—Betamethasone—psoriatic arthritis	0.00286	0.00761	CcSEcCtD
Alosetron—Acne—Dexamethasone—psoriatic arthritis	0.00263	0.00699	CcSEcCtD
Alosetron—Acne—Betamethasone—psoriatic arthritis	0.00263	0.00699	CcSEcCtD
Alosetron—Dermatitis atopic—Prednisone—psoriatic arthritis	0.0026	0.00692	CcSEcCtD
Alosetron—Ulcer—Triamcinolone—psoriatic arthritis	0.00257	0.00685	CcSEcCtD
Alosetron—Folliculitis—Methotrexate—psoriatic arthritis	0.00256	0.00681	CcSEcCtD
Alosetron—Constipation—Auranofin—psoriatic arthritis	0.00253	0.00674	CcSEcCtD
Alosetron—Contusion—Betamethasone—psoriatic arthritis	0.00253	0.00674	CcSEcCtD
Alosetron—Contusion—Dexamethasone—psoriatic arthritis	0.00253	0.00674	CcSEcCtD
Alosetron—Fungal infection—Prednisone—psoriatic arthritis	0.00249	0.00663	CcSEcCtD
Alosetron—Nail disorder—Methotrexate—psoriatic arthritis	0.00248	0.0066	CcSEcCtD
Alosetron—Urticaria—Auranofin—psoriatic arthritis	0.00235	0.00626	CcSEcCtD
Alosetron—Ulcer—Betamethasone—psoriatic arthritis	0.00234	0.00621	CcSEcCtD
Alosetron—Ulcer—Dexamethasone—psoriatic arthritis	0.00234	0.00621	CcSEcCtD
Alosetron—Burning sensation—Methotrexate—psoriatic arthritis	0.00231	0.00616	CcSEcCtD
Alosetron—Acne—Prednisone—psoriatic arthritis	0.00229	0.00608	CcSEcCtD
Alosetron—Contusion—Prednisone—psoriatic arthritis	0.0022	0.00587	CcSEcCtD
Alosetron—Injury—Prednisolone—psoriatic arthritis	0.00209	0.00556	CcSEcCtD
Alosetron—Fungal infection—Methotrexate—psoriatic arthritis	0.00208	0.00554	CcSEcCtD
Alosetron—Ulcer—Prednisone—psoriatic arthritis	0.00203	0.00541	CcSEcCtD
Alosetron—Injury—Triamcinolone—psoriatic arthritis	0.00192	0.00512	CcSEcCtD
Alosetron—Injury—Methylprednisolone—psoriatic arthritis	0.00192	0.00511	CcSEcCtD
Alosetron—Vomiting—Auranofin—psoriatic arthritis	0.00188	0.00501	CcSEcCtD
Alosetron—Rash—Auranofin—psoriatic arthritis	0.00187	0.00497	CcSEcCtD
Alosetron—Dermatitis—Auranofin—psoriatic arthritis	0.00187	0.00497	CcSEcCtD
Alosetron—Musculoskeletal stiffness—Methotrexate—psoriatic arthritis	0.00179	0.00477	CcSEcCtD
Alosetron—Nausea—Auranofin—psoriatic arthritis	0.00176	0.00468	CcSEcCtD
Alosetron—Injury—Dexamethasone—psoriatic arthritis	0.00174	0.00464	CcSEcCtD
Alosetron—Injury—Betamethasone—psoriatic arthritis	0.00174	0.00464	CcSEcCtD
Alosetron—Ulcer—Methotrexate—psoriatic arthritis	0.0017	0.00452	CcSEcCtD
Alosetron—Abdominal distension—Prednisolone—psoriatic arthritis	0.00167	0.00445	CcSEcCtD
Alosetron—Cystitis noninfective—Methotrexate—psoriatic arthritis	0.00157	0.00418	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.00156	0.00414	CcSEcCtD
Alosetron—Cystitis—Methotrexate—psoriatic arthritis	0.00155	0.00413	CcSEcCtD
Alosetron—Abdominal distension—Triamcinolone—psoriatic arthritis	0.00154	0.00409	CcSEcCtD
Alosetron—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.00153	0.00408	CcSEcCtD
Alosetron—Injury—Prednisone—psoriatic arthritis	0.00152	0.00404	CcSEcCtD
Alosetron—Urine output increased—Methotrexate—psoriatic arthritis	0.00145	0.00387	CcSEcCtD
Alosetron—Bladder pain—Methotrexate—psoriatic arthritis	0.00145	0.00387	CcSEcCtD
Alosetron—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00142	0.00378	CcSEcCtD
Alosetron—Haemoglobin—Prednisolone—psoriatic arthritis	0.00134	0.00356	CcSEcCtD
Alosetron—Haemorrhage—Prednisolone—psoriatic arthritis	0.00133	0.00354	CcSEcCtD
Alosetron—Polyuria—Methotrexate—psoriatic arthritis	0.00133	0.00354	CcSEcCtD
Alosetron—Sweating—Methylprednisolone—psoriatic arthritis	0.0013	0.00347	CcSEcCtD
Alosetron—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00125	0.00333	CcSEcCtD
Alosetron—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00125	0.00333	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00123	0.00328	CcSEcCtD
Alosetron—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00123	0.00327	CcSEcCtD
Alosetron—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00123	0.00326	CcSEcCtD
Alosetron—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00122	0.00325	CcSEcCtD
Alosetron—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00122	0.00325	CcSEcCtD
Alosetron—Abdominal distension—Prednisone—psoriatic arthritis	0.00122	0.00323	CcSEcCtD
Alosetron—Arrhythmia—Prednisolone—psoriatic arthritis	0.00119	0.00316	CcSEcCtD
Alosetron—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00111	0.00297	CcSEcCtD
Alosetron—Haemoglobin—Betamethasone—psoriatic arthritis	0.00111	0.00297	CcSEcCtD
Alosetron—Haemorrhage—Betamethasone—psoriatic arthritis	0.00111	0.00295	CcSEcCtD
Alosetron—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00111	0.00295	CcSEcCtD
Alosetron—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00109	0.00291	CcSEcCtD
Alosetron—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00109	0.0029	CcSEcCtD
Alosetron—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00109	0.0029	CcSEcCtD
Alosetron—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00107	0.00286	CcSEcCtD
Alosetron—Depression—Prednisone—psoriatic arthritis	0.00107	0.00286	CcSEcCtD
Alosetron—Malaise—Prednisolone—psoriatic arthritis	0.00104	0.00278	CcSEcCtD
Alosetron—Hypertension—Prednisolone—psoriatic arthritis	0.000999	0.00266	CcSEcCtD
Alosetron—Arrhythmia—Betamethasone—psoriatic arthritis	0.000991	0.00264	CcSEcCtD
Alosetron—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000991	0.00264	CcSEcCtD
Alosetron—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000987	0.00263	CcSEcCtD
Alosetron—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000985	0.00262	CcSEcCtD
Alosetron—Alopecia—Dexamethasone—psoriatic arthritis	0.00098	0.00261	CcSEcCtD
Alosetron—Alopecia—Betamethasone—psoriatic arthritis	0.00098	0.00261	CcSEcCtD
Alosetron—Discomfort—Prednisolone—psoriatic arthritis	0.000973	0.00259	CcSEcCtD
Alosetron—Haemoglobin—Prednisone—psoriatic arthritis	0.000971	0.00258	CcSEcCtD
Alosetron—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000967	0.00257	CcSEcCtD
Alosetron—Haemorrhage—Prednisone—psoriatic arthritis	0.000966	0.00257	CcSEcCtD
Alosetron—Malaise—Triamcinolone—psoriatic arthritis	0.00096	0.00255	CcSEcCtD
Alosetron—Malaise—Methylprednisolone—psoriatic arthritis	0.000958	0.00255	CcSEcCtD
Alosetron—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000937	0.00249	CcSEcCtD
Alosetron—Cough—Triamcinolone—psoriatic arthritis	0.000929	0.00247	CcSEcCtD
Alosetron—Hypertension—Triamcinolone—psoriatic arthritis	0.000919	0.00245	CcSEcCtD
Alosetron—Hypertension—Methylprednisolone—psoriatic arthritis	0.000917	0.00244	CcSEcCtD
Alosetron—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000913	0.00243	CcSEcCtD
Alosetron—Myalgia—Triamcinolone—psoriatic arthritis	0.000906	0.00241	CcSEcCtD
Alosetron—Myalgia—Methylprednisolone—psoriatic arthritis	0.000904	0.00241	CcSEcCtD
Alosetron—Anxiety—Methylprednisolone—psoriatic arthritis	0.000901	0.0024	CcSEcCtD
Alosetron—Depression—Methotrexate—psoriatic arthritis	0.000897	0.00239	CcSEcCtD
Alosetron—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000896	0.00238	CcSEcCtD
Alosetron—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000896	0.00238	CcSEcCtD
Alosetron—Discomfort—Triamcinolone—psoriatic arthritis	0.000895	0.00238	CcSEcCtD
Alosetron—Discomfort—Methylprednisolone—psoriatic arthritis	0.000893	0.00238	CcSEcCtD
Alosetron—Dry mouth—Triamcinolone—psoriatic arthritis	0.000886	0.00236	CcSEcCtD
Alosetron—Confusional state—Methylprednisolone—psoriatic arthritis	0.000874	0.00233	CcSEcCtD
Alosetron—Malaise—Dexamethasone—psoriatic arthritis	0.000871	0.00232	CcSEcCtD
Alosetron—Malaise—Betamethasone—psoriatic arthritis	0.000871	0.00232	CcSEcCtD
Alosetron—Arrhythmia—Prednisone—psoriatic arthritis	0.000863	0.0023	CcSEcCtD
Alosetron—Infection—Triamcinolone—psoriatic arthritis	0.000863	0.0023	CcSEcCtD
Alosetron—Sweating—Methotrexate—psoriatic arthritis	0.000862	0.00229	CcSEcCtD
Alosetron—Infection—Methylprednisolone—psoriatic arthritis	0.000861	0.00229	CcSEcCtD
Alosetron—Alopecia—Prednisone—psoriatic arthritis	0.000854	0.00227	CcSEcCtD
Alosetron—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000842	0.00224	CcSEcCtD
Alosetron—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00084	0.00223	CcSEcCtD
Alosetron—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000838	0.00223	CcSEcCtD
Alosetron—Hypertension—Dexamethasone—psoriatic arthritis	0.000834	0.00222	CcSEcCtD
Alosetron—Hypertension—Betamethasone—psoriatic arthritis	0.000834	0.00222	CcSEcCtD
Alosetron—Myalgia—Dexamethasone—psoriatic arthritis	0.000822	0.00219	CcSEcCtD
Alosetron—Myalgia—Betamethasone—psoriatic arthritis	0.000822	0.00219	CcSEcCtD
Alosetron—Anxiety—Dexamethasone—psoriatic arthritis	0.000819	0.00218	CcSEcCtD
Alosetron—Anxiety—Betamethasone—psoriatic arthritis	0.000819	0.00218	CcSEcCtD
Alosetron—Discomfort—Dexamethasone—psoriatic arthritis	0.000812	0.00216	CcSEcCtD
Alosetron—Discomfort—Betamethasone—psoriatic arthritis	0.000812	0.00216	CcSEcCtD
Alosetron—Haemoglobin—Methotrexate—psoriatic arthritis	0.000811	0.00216	CcSEcCtD
Alosetron—Pain—Prednisolone—psoriatic arthritis	0.000808	0.00215	CcSEcCtD
Alosetron—Haemorrhage—Methotrexate—psoriatic arthritis	0.000807	0.00215	CcSEcCtD
Alosetron—Hepatitis—Methotrexate—psoriatic arthritis	0.000807	0.00215	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000791	0.00211	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00079	0.0021	CcSEcCtD
Alosetron—Infection—Betamethasone—psoriatic arthritis	0.000783	0.00208	CcSEcCtD
Alosetron—Infection—Dexamethasone—psoriatic arthritis	0.000783	0.00208	CcSEcCtD
Alosetron—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00078	0.00208	CcSEcCtD
Alosetron—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000778	0.00207	CcSEcCtD
Alosetron—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000762	0.00203	CcSEcCtD
Alosetron—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000762	0.00203	CcSEcCtD
Alosetron—Malaise—Prednisone—psoriatic arthritis	0.000758	0.00202	CcSEcCtD
Alosetron—Urticaria—Prednisolone—psoriatic arthritis	0.00075	0.002	CcSEcCtD
Alosetron—Fatigue—Triamcinolone—psoriatic arthritis	0.000749	0.00199	CcSEcCtD
Alosetron—Fatigue—Methylprednisolone—psoriatic arthritis	0.000747	0.00199	CcSEcCtD
Alosetron—Pain—Triamcinolone—psoriatic arthritis	0.000743	0.00198	CcSEcCtD
Alosetron—Hypertension—Prednisone—psoriatic arthritis	0.000726	0.00193	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000718	0.00191	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000718	0.00191	CcSEcCtD
Alosetron—Myalgia—Prednisone—psoriatic arthritis	0.000716	0.00191	CcSEcCtD
Alosetron—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000716	0.0019	CcSEcCtD
Alosetron—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000714	0.0019	CcSEcCtD
Alosetron—Anxiety—Prednisone—psoriatic arthritis	0.000714	0.0019	CcSEcCtD
Alosetron—Alopecia—Methotrexate—psoriatic arthritis	0.000713	0.0019	CcSEcCtD
Alosetron—Discomfort—Prednisone—psoriatic arthritis	0.000707	0.00188	CcSEcCtD
Alosetron—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000696	0.00185	CcSEcCtD
Alosetron—Urticaria—Triamcinolone—psoriatic arthritis	0.00069	0.00184	CcSEcCtD
Alosetron—Urticaria—Methylprednisolone—psoriatic arthritis	0.000689	0.00183	CcSEcCtD
Alosetron—Infection—Prednisone—psoriatic arthritis	0.000682	0.00181	CcSEcCtD
Alosetron—Fatigue—Betamethasone—psoriatic arthritis	0.000679	0.00181	CcSEcCtD
Alosetron—Fatigue—Dexamethasone—psoriatic arthritis	0.000679	0.00181	CcSEcCtD
Alosetron—Pain—Dexamethasone—psoriatic arthritis	0.000674	0.00179	CcSEcCtD
Alosetron—Pain—Betamethasone—psoriatic arthritis	0.000674	0.00179	CcSEcCtD
Alosetron—Skin disorder—Prednisone—psoriatic arthritis	0.000667	0.00177	CcSEcCtD
Alosetron—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000664	0.00177	CcSEcCtD
Alosetron—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000652	0.00174	CcSEcCtD
Alosetron—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000649	0.00173	CcSEcCtD
Alosetron—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000649	0.00173	CcSEcCtD
Alosetron—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00064	0.0017	CcSEcCtD
Alosetron—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000639	0.0017	CcSEcCtD
Alosetron—Malaise—Methotrexate—psoriatic arthritis	0.000634	0.00169	CcSEcCtD
Alosetron—Urticaria—Dexamethasone—psoriatic arthritis	0.000626	0.00167	CcSEcCtD
Alosetron—Urticaria—Betamethasone—psoriatic arthritis	0.000626	0.00167	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000625	0.00166	CcSEcCtD
Alosetron—Asthenia—Triamcinolone—psoriatic arthritis	0.000623	0.00166	CcSEcCtD
Alosetron—Asthenia—Methylprednisolone—psoriatic arthritis	0.000622	0.00165	CcSEcCtD
Alosetron—Cough—Methotrexate—psoriatic arthritis	0.000613	0.00163	CcSEcCtD
Alosetron—Myalgia—Methotrexate—psoriatic arthritis	0.000598	0.00159	CcSEcCtD
Alosetron—Rash—Prednisolone—psoriatic arthritis	0.000596	0.00158	CcSEcCtD
Alosetron—Dermatitis—Prednisolone—psoriatic arthritis	0.000595	0.00158	CcSEcCtD
Alosetron—Fatigue—Prednisone—psoriatic arthritis	0.000592	0.00157	CcSEcCtD
Alosetron—Headache—Prednisolone—psoriatic arthritis	0.000592	0.00157	CcSEcCtD
Alosetron—Discomfort—Methotrexate—psoriatic arthritis	0.000591	0.00157	CcSEcCtD
Alosetron—Constipation—Prednisone—psoriatic arthritis	0.000587	0.00156	CcSEcCtD
Alosetron—Confusional state—Methotrexate—psoriatic arthritis	0.000578	0.00154	CcSEcCtD
Alosetron—Infection—Methotrexate—psoriatic arthritis	0.00057	0.00152	CcSEcCtD
Alosetron—Feeling abnormal—Prednisone—psoriatic arthritis	0.000566	0.00151	CcSEcCtD
Alosetron—Asthenia—Betamethasone—psoriatic arthritis	0.000565	0.0015	CcSEcCtD
Alosetron—Asthenia—Dexamethasone—psoriatic arthritis	0.000565	0.0015	CcSEcCtD
Alosetron—Nausea—Prednisolone—psoriatic arthritis	0.000561	0.00149	CcSEcCtD
Alosetron—Skin disorder—Methotrexate—psoriatic arthritis	0.000557	0.00148	CcSEcCtD
Alosetron—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000555	0.00148	CcSEcCtD
Alosetron—Vomiting—Triamcinolone—psoriatic arthritis	0.000552	0.00147	CcSEcCtD
Alosetron—Vomiting—Methylprednisolone—psoriatic arthritis	0.000551	0.00147	CcSEcCtD
Alosetron—Rash—Triamcinolone—psoriatic arthritis	0.000548	0.00146	CcSEcCtD
Alosetron—Dermatitis—Triamcinolone—psoriatic arthritis	0.000547	0.00146	CcSEcCtD
Alosetron—Rash—Methylprednisolone—psoriatic arthritis	0.000546	0.00145	CcSEcCtD
Alosetron—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000546	0.00145	CcSEcCtD
Alosetron—Urticaria—Prednisone—psoriatic arthritis	0.000545	0.00145	CcSEcCtD
Alosetron—Headache—Triamcinolone—psoriatic arthritis	0.000544	0.00145	CcSEcCtD
Alosetron—Headache—Methylprednisolone—psoriatic arthritis	0.000543	0.00144	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000523	0.00139	CcSEcCtD
Alosetron—Nausea—Triamcinolone—psoriatic arthritis	0.000516	0.00137	CcSEcCtD
Alosetron—Nausea—Methylprednisolone—psoriatic arthritis	0.000515	0.00137	CcSEcCtD
Alosetron—Hypersensitivity—Prednisone—psoriatic arthritis	0.000506	0.00135	CcSEcCtD
Alosetron—Vomiting—Betamethasone—psoriatic arthritis	0.000501	0.00133	CcSEcCtD
Alosetron—Vomiting—Dexamethasone—psoriatic arthritis	0.000501	0.00133	CcSEcCtD
Alosetron—Rash—Betamethasone—psoriatic arthritis	0.000497	0.00132	CcSEcCtD
Alosetron—Rash—Dexamethasone—psoriatic arthritis	0.000497	0.00132	CcSEcCtD
Alosetron—Dermatitis—Dexamethasone—psoriatic arthritis	0.000496	0.00132	CcSEcCtD
Alosetron—Dermatitis—Betamethasone—psoriatic arthritis	0.000496	0.00132	CcSEcCtD
Alosetron—Fatigue—Methotrexate—psoriatic arthritis	0.000495	0.00132	CcSEcCtD
Alosetron—Headache—Betamethasone—psoriatic arthritis	0.000494	0.00131	CcSEcCtD
Alosetron—Headache—Dexamethasone—psoriatic arthritis	0.000494	0.00131	CcSEcCtD
Alosetron—Asthenia—Prednisone—psoriatic arthritis	0.000492	0.00131	CcSEcCtD
Alosetron—Pain—Methotrexate—psoriatic arthritis	0.000491	0.00131	CcSEcCtD
Alosetron—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000473	0.00126	CcSEcCtD
Alosetron—Nausea—Betamethasone—psoriatic arthritis	0.000468	0.00125	CcSEcCtD
Alosetron—Nausea—Dexamethasone—psoriatic arthritis	0.000468	0.00125	CcSEcCtD
Alosetron—Urticaria—Methotrexate—psoriatic arthritis	0.000456	0.00121	CcSEcCtD
Alosetron—Vomiting—Prednisone—psoriatic arthritis	0.000436	0.00116	CcSEcCtD
Alosetron—Rash—Prednisone—psoriatic arthritis	0.000433	0.00115	CcSEcCtD
Alosetron—Dermatitis—Prednisone—psoriatic arthritis	0.000432	0.00115	CcSEcCtD
Alosetron—Headache—Prednisone—psoriatic arthritis	0.00043	0.00114	CcSEcCtD
Alosetron—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000423	0.00112	CcSEcCtD
Alosetron—Asthenia—Methotrexate—psoriatic arthritis	0.000412	0.0011	CcSEcCtD
Alosetron—Nausea—Prednisone—psoriatic arthritis	0.000408	0.00108	CcSEcCtD
Alosetron—Vomiting—Methotrexate—psoriatic arthritis	0.000365	0.000971	CcSEcCtD
Alosetron—Rash—Methotrexate—psoriatic arthritis	0.000362	0.000962	CcSEcCtD
Alosetron—Dermatitis—Methotrexate—psoriatic arthritis	0.000361	0.000962	CcSEcCtD
Alosetron—Headache—Methotrexate—psoriatic arthritis	0.000359	0.000956	CcSEcCtD
Alosetron—Nausea—Methotrexate—psoriatic arthritis	0.000341	0.000907	CcSEcCtD
